M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Total Current Assets Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Total Current Assets
$514.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Current Assets
$336.3m
CAGR 3-Years
-9%
CAGR 5-Years
19%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Current Assets
CHf180.5m
CAGR 3-Years
-4%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Current Assets
$1.9B
CAGR 3-Years
-8%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Total Current Assets
CHf165.6m
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Total Current Assets
CHf18.1m
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Total Current Assets?
Total Current Assets
514.2m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Total Current Assets amounts to 514.2m USD.

What is MoonLake Immunotherapeutics's Total Current Assets growth rate?
Total Current Assets CAGR 1Y
572%

Over the last year, the Total Current Assets growth was 572%.

Back to Top